2.3.1.180: beta-ketoacyl-[acyl-carrier-protein] synthase III
This is an abbreviated version!
For detailed information about beta-ketoacyl-[acyl-carrier-protein] synthase III, go to the full flat file.
Word Map on EC 2.3.1.180
-
2.3.1.180
-
malonyl-acp
-
thiolactomycin
-
transacylase
-
mycolic
-
drug development
-
acyl-acps
-
claisen
-
glaucescens
-
isobutyryl-coa
-
transacylation
-
cuphea
-
pharmacology
-
malonyl-coa:acp
-
bcfas
-
synthesis
-
biofuel production
-
medicine
- 2.3.1.180
- malonyl-acp
- thiolactomycin
-
transacylase
-
mycolic
- drug development
- acyl-acps
-
claisen
- glaucescens
- isobutyryl-coa
-
transacylation
- cuphea
- pharmacology
-
malonyl-coa:acp
-
bcfas
- synthesis
- biofuel production
- medicine
Reaction
Synonyms
3-ketoacyl ACP synthase III, 3-ketoacyl acyl carrier protein synthase III, 3-ketoacyl carrier protein synthase III, 3-ketoacyl-(acyl carrier protein) synthase IIIA, 3-ketoacyl-(acyl carrier protein) synthase IIIB, 3-ketoacyl-ACP synthase III, 3-ketoacyl-acyl carrier protein synthase III, 3-ketoacyl-acyl-carrier protein synthase III, 3-oxoacyl-ACP synthase III, 3-oxoacyl-acyl carrier protein synthase III, 3-oxoacyl-[acyl-carrier-protein] synthase III, 3-oxoacyl:ACP synthase III, AbyA1, acetoacetyl-ACP synthase, acetyl-CoA:ACP transacylase, acetyl-CoA:malonyl-[acyl-carrier-protein] C-acyltransferase, ACO synthase III, ACP synthase III, AknE2, AlnI, AsuC3, AsuC4, AviN, BenQ, beta-ketoacyl (acyl carrier protein) synthase III, beta-ketoacyl acyl carrier protein synthase III, beta-ketoacyl acyl-carrier protein synthase III, beta-ketoacyl-(ACP) synthase III, beta-ketoacyl-(acyl-carrier-protein) synthase III, beta-ketoacyl-ACP III, beta-ketoacyl-ACP synthase, beta-ketoacyl-ACP synthase III, beta-ketoacyl-ACP synthase III-like protein, beta-ketoacyl-ACP-synthase III, beta-ketoacyl-acyl carrier protein (ACP) synthase III, beta-ketoacyl-acyl carrier protein synthase III, beta-ketoacyl-acyl carrier protein synthase-III, beta-ketoacyl-[acyl-carrier protein (ACP)] synthase III, beta-ketoacyl-[acyl-carrier-protein] synthase III, beta-ketoacyl:acyl carrier protein synthase III, beta-ketoacylacylcarrier protein synthase III, beta-ketobutyryl-ACP synthase, BomK, CalO4, CerJ, ChlB3, ChlB6, CorB, DarB, DpsC, ecFabH, ecKAS III, efFabH, EsmD1, EvrI, FabH, FabH1, FabH2, FabH3, FabHA, FabHB, fatty acid biosynthesis, enzyme H, fatty acid synthase type II condensing enzyme, FdmS, FrenI/FrnI, HedS, hiFabH, initiation ketosynthase, JcKAS III, KAS III, KAS III-like protein, KAS IIIA, KAS IIIB, KAS-III, KAS3a, KAS3b, KASIII, KijB, LstA, LstAB, LstB, mtFabH, MxnB, nmFabH, NphT7, NzsF, paFabH, PpyS, PqsBC, PqsD, PtmR, RedP, RevR, RkD, saFabH, SalQ/Orf12, short-chain condensing enzyme, spFabH, spyFabH, SsfN, TcsB, ThgI, TiaF, Tmn15, [acyl-carrier-protein] synthase III
ECTree
2.3.1.180 beta-ketoacyl-[acyl-carrier-protein] synthase IIIAdvanced search results
results (
results (Application
Application on EC 2.3.1.180 - beta-ketoacyl-[acyl-carrier-protein] synthase III
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
top
APPLICATION 
ORGANISM
UNIPROT
COMMENTARY 
LITERATURE
biofuel production
-
the enzyme is interesting in order to develop engineered high oil-yielding microalgal strains for biofuel production
drug development
medicine
-
the enzyme is a target of antibacterial treatment of the pathogen Staphylococcus aureus
pharmacology
synthesis
-
the recombinant enzyme is useful for production of fatty acids by directed biosynthesis profiting of the flexible substrate specificity for acyl-CoAs of the enzyme, overview
drug development
-
the enzyme represents a target for structure-based design of antimycobacterial agents
drug development
-
the highly conserved enzyme is an attractive target for antimicrobial inhibitor design
drug development
the enzyme is a target for inhibitor development
drug development
-
FabH is a particularly attractive target for design of antibacterial agents since it is central to the initiation of fatty acid biosynthesis and is highly conserved among Gram positive and negative bacteria
drug development
FabH is an attractive target for the development of antibacterial agents
drug development
beta-ketoacyl-ACP-synthase III (FabH or KAS III) has become an attractive target for the development of antibacterial agents which can overcome the multidrug resistance
drug development
the enzyme is a potential target for anti-infection drug discovery, the dimer interface in FabH is potentially a viable target for designing another class of inhibitors
drug development
-
the enzyme is a promising target for the development of therapeutic agents
drug development
the enzyme is a promising target for the development of therapeutic agents
drug development
the enzyme is a promising target for the development of therapeutic agents
drug development
the enzyme is a promising target for the development of therapeutic agents
drug development
the enzyme is a promising target for the development of therapeutic agents
drug development
-
the enzyme is a promising target for the development of therapeutic agents
-
drug development
-
beta-ketoacyl-ACP-synthase III (FabH or KAS III) has become an attractive target for the development of antibacterial agents which can overcome the multidrug resistance
-
drug development
-
the enzyme is a target for inhibitor development
-
drug development
-
the enzyme is a promising target for the development of therapeutic agents
-
pharmacology
the enzyme is a target for design and development of antibacterial drugs against pathogenic bacteria
pharmacology
-
the enzyme is a target for development of antibiotics
pharmacology
-
the enzyme is a target for development of inhibitors for treatment of the multi-drug resistant pathogen Staphylococcus aureus
